CLNN · Clene Inc
United States · RS rating 7 · As of 2026-10-14
| Price | 3.31 USD |
|---|---|
| 1-day change | -2.4% |
| RS rating (overall / 1M / 3M / 12M) | 7 / 13 / 7 / 11 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 25 / 4 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -56.5% |
| Sales growth Q/Q | +413.3% |
| Distance from 52-week high | +73.5% |
| Market cap (USD) | $72.4M |